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Summary 
Endothelioma cell lines transformed by polyoma vtrus middle T antigen (mTa) cause cavernous 
hemangiomas in syngenelc mice by recruitment of host cells. The production of nitric oxide 
(NO), as measured by nitrite and citruUine production, was s~gnificantly  higher in mTa-transformed 
endothelial cells in comparison with nontransformed control cells. The maximal activity of NO 
synthase  (NOS) was about 200-fold higher in cell lysates from the tEnd.1 endothelioma cell 
line than in lysates from nontransformed controls, whereas the affinity for arginine did not differ. 
The biochemical characterization of NOS and the study of mRNA transcripts indicate that tEnd.1 
cells express both the inducible and the constitutive isoforms. NOS hyperactivity is not a simple 
consequence of celt transformation but needs a tissue-specific mTa expression.  Since tEnd.I- 
conditioned medium induces NOS  activity in  normal endothelial cells,  most likely  NOS 
hyperactivity in endothelioma cells is atmbutabte to the release of a soluble factor. This NOS- 
activating factor, which seems to be an anionic protein, could stimulate tend.1 cells to express 
NOS by an autocrine way.  By the same mechanism, tend.1 cells could induce NOS m  the 
neighboring endothelial cells, and NO release could play a role in the hemangloma development. 
Such hypothesis is confirmed by our in vivo experiments, showing that the administration of 
the NOS inhibitor t-canavanme to endothehoma-bearmg mice significantly  reduced both the 
volume and the relapse time of the tumor. 
N 
'itnc oxide (NO) * is a short-hved free radical gas pro- 
duced by various  cell  types,  including vascular  en- 
dothelial cells (1-3).  In endothelium, NO is synthesized m 
response to a large number of stimuli and displays an enlarging 
spectrum of activities, such as smooth muscle relaxation,  in- 
hibition of platelet aggregation and adhesion, and decrease 
of smooth muscle cells prohferatlon (4, 5). NO generation 
is catalyzed by a class of NADPH-dependent NO synthases 
t Abbrevtattons used m th~s paper eNOS,  endothehal  NOS,  HUVEC, 
human umbthcal veto endothehal cells, 1NOS, mductble NOS, L-ArgMEE, 
L-argmme monoethylester,  L-NAME, NC-mtro-t-argmme  methylester, 
L-NMMA, NC-monomethyl-t-argmme  hydrochlonde,  MAEC, munne 
aorta endothehal cell, rata, middle T anttgen; NAF, NOS-actlvatmg factor, 
NO, mtnc oxide, NOS, mtrlc oxide synthase, Vmax, maximal rate 
(NOS), which favor the conversion of t-arginine m t-dtruUme 
and NO with a 1:1 stoichlometry, and are competitively in- 
hibited by N~  t-arginine analogues  (6,  7).  At 
least three different lsoenzymes have been characterized  (8, 
9).  Both a constitutive, Ca2+-dependent NOS  (cNOS or 
eNOS) and an inducible, CF +-independent enzyme (iNOS) 
have been detected in endothelial cells (10-13).  Because of 
its short half-life, direct measurement of NO concentration 
is dif~cult, and several indirect techmques of detection have 
been developed. A simple and sensitive procedure monitors 
the conversion of [3H]arginine  to [3H]citrulline,  which is 
stoichiometric with NO  (14, 15) 
Established cell lines of transformed endothehal cells could 
represent useful tools to investigate the synthesis and the bi- 
ological roles of NO. Several  endothelioma  cell lines have been 
J  Exp  Med  ￿9  The Rockefeller Umverslty Press ￿9 0022-1007/95/01/0009/11  $2 00 
Volume 181  January 1995  9-19 established from cavernous hemangiomas developed m mice 
infected with polyoma virus middle T oncogene (16). Middle 
T antigen (raTa) expression is sufficient to induce malignant 
transformation in endothelial cells and their establishment 
m  vitro. Murme endothelial cells transformed m vivo (16) 
or m vitro (17, 18) by polyoma mTa retain functional proper- 
ties of normal endothelial cells. These cells prohferate at 
confluence without aspects of overgrowth; uptake acetylated 
low density lipoproteins; express CD31, vascular cell adhe- 
sion molecule 1, E- and P-selectin;  respond to IL-1,  TNF, 
and specific endothelial cell growth factors; and produce IL-6 
and chemokines (16-19).  However, mTa-transformed  endo- 
thelial cells injected in syngeneic or in lmmunodeficient mice 
cause vascular  les~ons. H~stologlcally,  the tumors have the 
features of a hemangioma with areas resembling Kaposi's sar- 
coma or w~th lacunae lined by vascular endothelium (16, 18). 
The growth of th~s tumor ~s characterized by the recruit- 
ment of host endothelial cells (18, 20).  The mechanisms of 
m wvo recruitment of host cells are not well known, mTa- 
transformed endothelial cells release chemokines able to re- 
cruit macrophages, which in turn produce angaogemc/chemo- 
tactic factors, leading to the progression of the lesion. It has 
been found that mTa-transformed  endothelial cells produce 
a  40-kD  cytokme, distinct  from the  vascular  endothelial 
growth factor, which induces migration of vascular endothelial 
cells (21). Furthermore, an unbalance between urokanase-type 
plasminogen activator and ~ts inhibitor may favor an abnormal 
degradation of extracellular matrix which permits the migra- 
tion of host cells (22).  These data support a new concept 
of a tumor sustained by a minute population of transformed 
cells, which recruit host elements and express malignant be- 
havior in the ~mmunodeficient host. 
The present work was designed to study m raTa-transformed 
endothelioma cells: (a) the synthesis of NO; (b) the proper- 
ties of the NOS lsoform(s) responsible for NO synthesis, (c) 
the mechanisms regulating NOS actlwty; and (d)  the role 
of NO  synthes~s in m  vivo tumor growth. 
Materials and Methods 
Reagents  Medmm 199 (wath or wlthout phenol red), Iscove's 
medaum, DMEM, and trypsm/EDTA were from GIBCO-RBC 
(Paisley, Scotland); FCS was from Irvme Scientific (Santa Ana, 
CA); plastic for cell culture was from Costar Italia (Mdan, Italy), 
NC-monomethyl-t-argmme hydrochlonde (t-NMMA)  was from 
Bachem Femchermkahen  AG (Bubendorf, Switzerland),  collagenase 
and lonomycm were provided by Boehnnger Mannhelm (Mann- 
helm, FRG), and t-[2, 3, 4, 5-3H]arganme monohydrochlonde (62 
C1/mmol) was from Amersham International (Amersham, Bucks, 
UK)  Other reagents were purchased from Sigma Chemical Co 
(St  Lores, MO).  Mouse mAb  anti-human endothehal cNOS 
(eNOS) and antl-munne macrophage 1NOS darected  against pro- 
tern fragments of 179 amino acids (eNOS, W 1~176  --- L lz~  and 183 
amino acids (tNOS, F  961 ~  Ll144), respectively,  were from Trans- 
ductlon Laboratories  (Ierangton, KY). Electrophoresls  reagents  were 
from Blo-Rad Laboratories (Hercules, CA)  The composmon of 
Hepes buffer was  as  follows (m  raM).  145  NaC1, 5 KC1, 1 
MgSO#, 10 Hepes (sodmm salt), 10 glucose, and 1 CaC12, pH 7 4, 
at 37~  Ionomycm was &ssolved at 1 mM m DMSO and stored 
at  -20~  until use. The protein content of cell monolayers was 
assessed with the modified micro-Lowry method (kit from Sigma 
Chemical Co.) 
Cell Cultures.  Human umbilical  veto endothehal  cells (HUVEC) 
and artery (HUAEC) were obtamed by treating human umbdlcal 
cord veins and arteries with coUagenase  from Clostridtum htstolyt~curn 
(Boehnnger Mannhelm) (10 mg/ml Iscove's medaum), cultured in 
75 cm  2 plastic flasks m me&urn 199 containing 20%  FCS and 
charactenzed as previously  described (23). ms-transformed  HUVEC 
(a gift of Dr  M. L. Lanfrancone, Pohdmlco Monteluce, Perugaa, 
Italy, and Dr. E. Dejana, Istltuto Mano Negn) were grown m 
me&um 199 with 20% FCS. 
Munne aorta endothehal  cells (MAEC) were prepared from male 
DBA2 mice (Charles Raver, Calco, Italy). Aortas were washed  with 
buffered saline and then incubated for 30 mm at 37~  with col- 
lagenase (10 mg/ml). Approximately 105 cells were recovered from 
each aorta and plated on 35-mm-&ameter petn dashes coated with 
collagen (1 mg/ml). Cells were grown m Iscove's medium con- 
taming 20%  FCS supplemented with 6 mg/hter transfemn,  5 
mg/liter lnsuhn, 100 rag/liter soybean leothm, 6.73 #g/hter so- 
&urn selemte, and 400 mg/hter BSA. Cells were characterized by 
the posmvity for factor VIII-related antigen (>87%) and by the 
uptake of acetylated low density hpoprotems (>90%) 
tEnd 1, sEnd.l, eEnd.1 (16), H End.FB (17), and HSV (18) mu- 
nne endothehal  cell  lines transformed  by mTa of  polyoma  vtrus were 
grown m DMEM supplemented  wtth 10% FCS J774 munne mac- 
rophage cell line was grown m DMEM containing 10% FCS 
N2A (murme neuroblastoma) cell hne (American Type Culture 
Collection, Rockville,  MD) was cultured m 100-mm-&ameter  petn 
&shes (~106 cells) for 24 h in DMEM with 10% FCS  Cells were 
then exposed overmght to 3  x  10  s neo CFU/ml of the retrovlrus 
vector N-TKmT (16) Medium was changed and cells cultured for 
72 h, then selected m the presence of I mg/ml G418. Growth of 
G418-reslstant cells was observed after 3 wk and G418 was used 
for an addmonal month; cells were then grown without ~t. rata 
insertion was evaluated  by Southern blot analysis After electropho- 
resls, 10/zg of EcoKI-&gested genomlc DNA was blotted on a 
nylon filter and hybri&zed with a specific cDNA probe for rata. 
The probe, a 1 5-kb BamHI-EcoRI fragment ofpLJ vector (kindly 
provided by Dr. B. J. Druker, Dana Farber Cancer Institute, Boston, 
MA) was labeled wath ot-[o2p]dCTP by a random primer labehng 
method (Amersham International). Posthybn&zatlon washes were 
performed at high stnngency and the membrane was exposed on 
autoradaography.  After infection and selectlon, these N2A cells in- 
tegrated middle T gene 
Measurement of Nitrite.  Nitrite  production was measured by 
adding 0.6 ml of cell culture medmm to 0.6 ml of Gness reagent 
(24), and, after 30 mm incubation at room temperature m the dark, 
absorbance was  measured at  540  nm  m  a  spectrophotometer 
(UWVis; Perkm Elmer, Norwalk, CT)  To rule out measurement 
interferences by pH m&cators, culture medaum was prebleached 
by adding a few milhgrams per mdhliter charcoal (which &d not 
mo&fy the cahbration curve), alternatively,  commercially  avadable 
phenol red-frec medium was used. 
Measurement of Citrulline Synthesis as a Sens~twe Marker of NO 
Production.  CitruUine  synthesis  was measured  both by a radiomemc 
method (detection of mtracellular concentration after short t~me 
experiments) and by a colorimetmc method (measurement of ex- 
tracellular cltrulhne accumulauon  dunng long-lasting  incubations) 
The former was modified from a prewously described technique 
(14, 15). Cells grown at confluence  m 35-ram dishes were washed 
once with Hepes buffer, and then incubated vclth 1 ml of the same 
buffer at 37~  for 20  mm  5 #Cl t-[3H]argamne and  10 #M 
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to each dish, and cells were stimulated with 2 #M ionomycin (or 
DMSO as control); after 15 min, reaction was stopped by washing 
cells with cold PBS containing 5 mM t-arginine and 4 mM EDTA. 
After supernatant  removal, 0.5  ml ethanol  was  added  to each 
monolayer and allowed to evaporate;  2 ml of 20 mM Hepes-Na, 
pH 6, was then added. After 5 rain, supernatant was collected and 
applied to 2-ml columns of Dowex AG50WX-8 (Na + form) and 
eluted with 4  ml of water.  The radioactivity corresponding to 
[3H]citrulline  content in 6 ml eluate was measured by liquid scin- 
tillation counting. Citrulline synthesis was expressed as pmol citrul- 
line/min/mg cell protein. The colorimetric method for citrulline 
detection in the extracellular medium was performed as previously 
described (25). Briefly, cell supernatant was incubated with urease 
(2 U/ml for 30 min at 37~  After deproteinization with 5% 
TCA and centrifugation, 0.1 ml supernatant was allowed to boil 
for 5 min after mixing with 3 ml chromogenic solution, and ab- 
sorbance was  measured at 530 nm. 
Measurement of NOS Activity in Cell Lysates.  Cells  grown at 
confluence in  75  cm  2 flasks  were  detached  by  trypsin/EDTA 
(0.05/0.02%  vol/vol), the cells from 8 to 12 flasks were pooled 
and washed with PBS, then resuspended in 1 ml of reaction buffer 
([in mM] Hepes 20, EDTA 0.5, dithiothreitol 1, pH 7.2) and soni- 
cated on ice with three 10-s bursts. In each test tube, the following 
reagents were added to 100/~1 lysate at the final concentrations: 
2 mM NADPH,  1.5 mM CaCI~,  1-100/zM t-arginine, and 2.5 
#Ci r-[3H]arginine (0.4/~M) (14, 15). When indicated, NOS in- 
hibitors were added to the other reagents. After a 15 min incuba- 
tion at 37~  the reaction was stopped by adding 2 ml Hepes-Na, 
pH 6, containing 2 mM EDTA. The whole reaction mixture was 
passed through a Dowex column and [3H]citrulline~related radio- 
activity was counted, as indicated in the previous paragraph. 
mRNA Analysis of iNOS and eNOS.  Total RNA was obtained 
by the guanidine isothiocyanate/cesium chloride method (26). 25 
/~g of total RNA were electrophoresed on a 1% agarose gel con- 
taining 6.3% formaldehyde in 4-morpholinepropanesulfonic acid 
(MOPS) buffer and blotted on a Nylon Duralon-UV membrane 
(Stratagene, La Jolla, CA) by the traditional capillary system in 10x 
SSC (27). Prehybridization and hybridization steps were performed 
overnight in 50% deionized formamide, 10% dextran sulfate, 1 M 
NaC1, with 100/zg/ml denaturated salmon sperm DNA at 42~ 
The eDNA for endothelial eNOS (11) (a gift from Dr. T. Michel, 
Brigham and Women's Hospital, Boston, MA) and iNOS (28) (gift 
from Dr. C. Nathan, Cornell University Medical  College, New 
York) were labeled  with c~-[3~P]dCTP (3,000 Ci/mmol,  Amer- 
sham International) at 2.2  x  10  s cpm//zg sp act by the random 
primer labeling kit (Amersham International)  according to the 
manufacturer's instructions. Posthybridization washes  were per- 
formed at high stringency (twice in 2x  SSC plus 0.1% SDS for 
30 min at room temperature, twice in 0.2x  SSC plus 0.1% SDS 
for 30 min at room temperature, and twice in 0.1x SSC plus 0.1% 
SDS for 30 min at 55~  and the membrane was exposed on auto- 
radiography with Hyperfilm-MP (Amersham International) and 
intensifying screens at  -80~  for 20 d. 
Detection of iNOS and eNOS Proteins.  tend.1 cells and HUVEC 
were directly solubilized  in boiling Laemmli buffer and proteins 
separated by SDS-PAGE (8%), transferred to nitrocellulose sheets, 
and probed with a mAb anti-iNOS (1:500) and detected by en- 
hanced chemiluminescence (ECL; Amersham International). Al- 
ternatively, cells (107/plate) were lysed in 1 ml of 50 mM Tris-HC1 
buffer, pH 7.4, containing 150 mM NaC1,  1% Triton X-100, 50 
/zg/ml pepstatin, 100/zg/ml leupeptin, 10/~g/ml aprotinin, 2 mM 
PMSF, and 500/zg/ml soybean trypsin inhibitor. After centrifuga- 
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tion at 10,000 g for 20 rain, supematants were precleared by 1 h 
incubation with anti-mouse IgG-agarose and then incubated for 
2 h with the anti-eNOS antibodies at a concentration of 3/~g/ml. 
The immunoprecipitates, recovered on anti-mouse IgG-agarose, 
were washed four times with lysis buffer, twice with the same buffer 
without Triton X-100, twice with Tris-buffered saline, and solubi- 
lized with Laemmli buffer. Proteins were separated by SDS-PAGE 
(7%), transferred to nitrocellulose,  and probed with anti-eNOS 
antibody as described  above. 
Preparation and Characterization of Conditioned Medium.  Con- 
ditioned medium was prepared from tEnd.1 cells as follows: cells 
were grown at confluence in 150 cm  2 dishes and then incubated 
for 48 h with Iscove's medium containing LPS-free 0.45% BSA 
(GIBCO RBC). The cell viability assessed by trypan blue exclu- 
sion was >94%. The medium was centrifuged and used immedi- 
ately or concentrated by precipitation with 40% ammonium sul- 
phate and stored at 4~  in this condition activity was stable for 
2 wk. The precipitated medium was dialyzed against 20 mM Tris- 
HC1, pH 7.0, and then applied to a DEAE-Sephacel column (Phar- 
macia, Piscataway, NJ) equilibrated in 20 mM Tris-HC1, pH 7.0. 
The bound material was eluted by a stepwise gradient with NaC1 
(0.05,  0.1, 0.3, 0.5, 0.6, and 1 M). After correction of molarity, 
fractions were tested for their ability to enhance NOS in HUVEC 
after 12 h incubation. To assess the effect of enzymatic treatment, 
conditioned medium was treated with either DNase (10/~g/ml), 
RNase (50/~g/ml),  trypsin (100/~g/ml),  or chymotrypsin (100 
/~g/ml) at 37~  for 1 h. Trypsin and chymotrypsin were blocked 
by adding PMSF (1 mM). All samples were dialyzed against  PBS 
and tested on HUVEC. Lipids and phospholipids  from conditioned 
medium were extracted as previously described (29) and then tested 
on HUVEC. 
In Vivo Tumor Growth Assay.  The H5V endothelioma line was 
transplanted in syngeneic female C57BI/6NCrlBR mice (Charles 
River) as described (18). Animals (eight per group) were inocu- 
lated subcutaneously with 1@ HSV cells on day 0 and checked for 
tumor appearance and growth three times a week. Tumor growth 
was measured with calipers and its volume estimated by the for- 
mula:  length  x  width2/2. Animals were treated intraperitoneally 
with t-canavanine (30 mg/kg; Sigma Chemical Co.) in saline or 
saline alone from day 0 to day 28. 
Statistical Analysis.  Each experimental point was performed in 
duplicate or triplicate per experiment; all data in the text, table, 
and figures are given as means _+ SEM. Statistical analysis was car- 
tied out using the Student's t test for unpaired data. 
Results 
NO Synthesis in raTa-transformed Cells 
Nitrite Production.  After 24-h incubation of cells in cul- 
ture medium containing 1 mM t-arginine, nitrite concentra- 
tion was 1.83  +_  1.49 nmol/mg cell protein in the superna- 
tant of HUVEC cultures (n  =  5), whereas in tend.1 it was 
about  10-fold higher (18.73  +  3.84 nmol/mg cell protein, 
n  =  8, iv <0.008) (Fig. 1). In both cell types, nitrite concen- 
tration was  dose dependently correlated to t-arginine level 
in the culture medium: nitrite formation was not detectable 
in HUVEC  already at 0.1 mM t-arginine,  whereas it was 
still measurable in tend.1  in t-arginine-free medium (sug- 
gesting the presence of an intracellular pool of arginine for 
NO synthesis). A similar result was obtained when t-arginine 30 
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Figure  1.  Nitrite accumulation in the supernatant of HUVEC and 
tEnd.1 cells. After 24-h incubation in fresh medium containing different 
concentrations of t-arginine or its monoethylester derivative, nitrite con- 
centration was measured in the culture medium with the Griess reagent 
(see Materials and Methods). To provide  hemoglobin as scavenger  of NO, 
20/~1 of packed red blood cells (rbc) was added to the culture medium 
containing the highest arginine concentration. Data are means _+ SEM 
of results obtained from five (HUVEC) and eight (tEnd.l) experiments 
performed in duplicate. (Arg) I.-arginine; (ArgMEE) t-arginine mono- 
ethylester. 
served at the higher substrate concentrations in the medium 
(Fig.  1). 
Citrulline Synthesis (Short-term Incubation),  To detect NO 
synthesis in short time periods,  the intracellular content of 
citrulline was measured in cells incubated in the absence and 
in the presence of the Ca  ~  § ionophore ionomycin. The syn- 
thesis of citrulline after  15 min of incubation was maximal 
at  10/~M extracellular  t-arginine in HUVEC and 100 #M 
extracellular t-arginine in tend.1  cells (data not shown).  It 
was completely inhibited when cells were preincubated for 
20 min with 10 mM t-NMMA. Basal citrulline production 
(expressed  as  pmol/min/mg  protein)  was  1.24  +  0.18  in 
HUVEC (n  =  4)  and  10.35  +  2.85  in tend.1  cells (n  = 
3;/~ <0.02).  After 2 #M ionomycin stimulation,  citrulline 
synthesis (pmol/min/mg protein) was 7.07 +  1.14 in HUVEC 
(n  =  4) and 38.5  +  3.32 in tend.1 cells (n  =  3; p <0.0001). 
Citrulline Synthesis (Long-term Incubation).  Citrulline pro- 
duction was also measured in the supernatant of cells incubated 
for 24 h in the absence or in the presence of either r-arginine 
or t-ArgMEE (0.1-1 raM): extracellular citrulline, measured 
colorimetricaUy, was not detectable at any arginine concen- 
tration in HUVEC (n  =  6), whereas its synthesis was mea- 
surable in tEnd.1  (n  =  8) and was dependent  on substrate 
availability (although it  was detectable even in the absence 
of extracellular  arginine)  (Fig.  2). 
was replaced with r-arginine  monoethylester (r-ArgMEE), 
which permeates plasma membrane better than the standard 
amino acid. When red blood cells were added to the incuba- 
tion medium, in order to provide hemoglobin as a scavenger 
of NO, no production  of nitrite in both cell types was ob- 
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Figure  2.  Citrulline accumulation in the supernatant of HUVEC and 
tEnd.1 cells. After 24-h incubation in fresh medium containing different 
concentrations of  t-arginine or its monoethylester  derivative, citrulline con- 
centration was measured in the culture medium with the colorimetric pro- 
cedure of Boyde and Rahmatullah (25) (see Materials and Methods). 
Columns related to HUVEC are not visible, since dtrulline levels were 
not detectable at any condition in these cells. Data are means  •  SEM 
of results obtained from six (HUVEC) and eight (tEnd.l) experiments 
performed in duplicate. 
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Figure 3.  L-arginine  dependence of  NO synthase (NOS) from HUVEC 
(n = 4) and tEnd.1 (n =  4). Each point is represented as mean value _+ 
SEM; the curves are ideal plots obtained with the Michadis-Menten equa- 
tion: Y =  (X  x  Vmax)/(X + Km), where X  = t-arginine concentra- 
tion (0.4/.r  t-[3H]arginine +  1-100  #M t-arginine), and Vmax and Km 
are the values obtained  for each cell type  by Lineweaver-Burk  transformation. 
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Kinetics of NO Synthase Activity.  When NOS activity was 
measured in the cell lysates,  it exhibited a substrate depen- 
dence that followed a Michaelis-Menten pattern (Fig.  3). In 
HUVEC (n  =  4) maximal  rate (Vmax) was 3.32  _+  1.68 
pmol citrulline/min/mg  protein,  and half-maximal activity 
was detectable at 9.3  _+  1.54/xM t-arginine.  In tend.1 ceils 
(n  =  4) the enzyme kinetics showed a Vmax  =  702.93  _+ 
159.85 pmol citruUine/min/mg  protein (p  =  0.005), and a 
Km  =  9.49 _+  3.53/xM t-arginine  (p  =  NS). When cal- 
cium was not present in the test, the [3H]citrulline produc- 
tion was completely abolished in HUVEC, whereas it did 
not change in tend.1  lysate.  If ceUs were preincubated for 
24 h with 1 ~  dexamethasone,  NOS activity was not 
in HUVEC lysate, but it was inhibited by 75  _  10% (n  = 
3) in tend.1  lysate,  o-arginine,  ~<1 mM, did not influence 
the amount of [3H]citrulline produced by normal and trans- 
formed endothelial cells,  indicating  that  the D-enantiomer 
of arginine was not transformed by the lysate, and that NOS 
in both call types was stereospecific (data not shown). Fur- 
thermore, the two cell types exhibited a different pattern of 
NOS inhibition by a panel of three NOS inhibitors,  t-NMMA, 
r-NAME (NC-nitro-r-arginine  methylester), and t-canavanine 
(Fig.  4):  ICs0 values were,  respectively,  5.9 /zM,  36 /~M, 
and 1.52  mM  in  HUVEC,  and  1.43  mM,  41.1  mM,  and 
73/zM  in tEnd.1. 
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To exclude the presence of arginase activity, 50 mM t-valine 
(10) was added to the reaction mixture.  No change of the 
radioactivity in the column duate was detected, suggesting 
that arginase activity was virtually absent in HUVEC and 
tend.1  lysate.  An alternative  source of citrulline  in living 
systems is arginine deiminase, an enzyme converting I.-arginine 
into t-dtrulline and ammonia: its activity is detectable in bac- 
teria but not in mammalian cells (8). The existence of such 
an enzyme in our cells was rttled out as fonnam~dine,  a known 
inhibitor of arginine deiminase (15),  did not influence argi- 
nine conversion even at I mM concentration (data not shown). 
Moreover benzoylarglnlne ethylester, a substrate for arginine 
deiminase (15), did not show any competition with [3H]ar- 
ginine. Finally,  the concentration of extraceUular ammonia, 
as detected by Nessler reagent, was not significantly different 
in normal and transformed cells after 24 h of incubation (data 
not shown). 
NOS activity was also measured in cell lysates from the 
murine  neuroblastoma  cell  line  N2A,  infected  with  the 
retrovirus vector N-TKmT.  Although these cells expressed 
raTa, NOS activity was identical to that found in parental 
nontransfected cells, and in HUVEC and MAEC (Table 1). 
Similarly,  HUVEC transfected with K-ras did not show an 
increase  of enzyme activity.  On the contrary,  a very high 
NOS activity was detectable in the lysate of other murine 
endothelioma cell lines (sEnd.l, H.End.FB) obtained by mTa 
transfection  (16,  17,  and Table 1). 
Expression of mRNA for eNOS and iNOS.  We examined 
the capacity of murine endothelial cells transformed by mTa 
to express mRNA of endothelial cNOS and iNOS.  RNA 
was probed with specific cDNA for eNOS and iNOS and 
analyzed  by  Northern  blot  hybridization.  Endothdioma 
Table  1.  NOS Activity Measured in the Lysates of Different 
Cell Types 
Cell type  NOS activity  mTa  n 
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.-e 
v  ~0- 
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O  40- 
Z 
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~ml.1 
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Figure  4.  Dose-response curve of NOS activity in the lysate of HUVEC 
and tEnd.l, in the presence of three different NOS inhibitors. Measure- 
ment of enzymatic activity was performed as indicated in Materials and 
Methods, in the presence  of 2.5/~Ci (0.4/~M) t-[3H]arginine. Enzyme 
activity is expressed as percentage of NOS activity (assumed to be 100% 
in the absence of NOS inhibitors). Each point is a mean _+ SEM of three 
different  experiments performed in duplicate. 
HUVEC  0.34  _+  0.07  -  5 
HUAEC  0.25  _+  0.12  -  3 
MAEC  0.18  _+  0.10  -  3 
tend.1  62.2  _+  7.86  +  5 
send.1  34.2  _+  13.38  +  3 
H5V  52.3  _+  10.1  +  3 
H.End.FB  47.4  _+  11.72  +  3 
N2A  0.40  _+ 0.19  -  3 
mTa-N2A*  0.38  _+ 0.12  +  3 
ras-HUVEC*  0.55  _+ 0.34  -  3 
Measttrement of enzymatic activity was performed as indicated in Matesiais 
and Methods, in the presence of 2.5/zCi (0.4/xM) I.-[3H]arginine.  NOS 
activity is expressed  as pmol citrulline/min/mg cell protein (mean  _+ 
SEM).  The expression of mTa in each cell type is indicated. 
* N2A transfected with mTa. 
t HUVEC transfected with K-ras. 
13  Ghigo et al. (tEnd.1 and H.End.FB) cells expressed a specific eNOS tran- 
script (4.6  kb) with a size different from that observed in 
HUVEC (4.8 kb) (Fig.  5 A). To determine eNOS protein 
expression, cell lysates from untreated HUVEC and tend.1 
were immunoprecipitated with a mAb anti-human eNOS, 
followed by a Western blot analysis using the same antibody. 
This experiment indicates  that eNOS is two- to threefold 
more abundant in endothdioma cells than in HUVEC (Fig. 
6 A). Both cell types apparently did not express mILNA for 
iNOS, in contrast to routine macrophage J774 cells stimu- 
lated with LPS (Fig.  5 B).  After 16 h  of preincubation in 
the presence of 10 ~g/ml cycloheximide, iNOS mRNA (4.4 
kb) was detectable in tend.1 (Fig. 5 C), but not in HUVEC 
(data not shown). Actinomycin D  (10 ~g/ml) inhibited the 
effect of cycloheximide (Fig.  5 C).  To determine whether 
HUVEC and tEnd.1 cells expressed iNOS proteins, we car- 
ried out Western blot analysis of total cellular  proteins by 
using a mAb anti-murine macrophage iNOS. Fig. 6 B shows 
that tEnd.l, but not HUVEC, express a 130-kD protein rec- 
ognized by antibody anti-murine macrophage iNOS. 
Figure  5.  Expression  of mRNA for eNOS (A) and 
iNOS (B and C) in mTa-transformed and nontransformed 
endothelial cells. (,4) Northern blot analysis for mP,  NA 
levels of eNOS in HUVEC, tEnd.l, and H.End.FB. (B) 
Northern blot analysis for mRNA leveh of iNOS in  J774 
cells under control condition or stimulated for 4 h with 
LPS (10 ~g/ml) beffore  mKNA e~traction, and in tend.1 
and H.End.FB cell lines. (C') Northern blot analysis for 
mKNA levels ofiNOS in tEnd.1 cells under control con- 
ditions (-) or after 16-h incubation with cycloheximide 
(CX, 10 ~g/ml)  or cycloh~mimide and actinomycin D 
(CX+AC, both at 10 ~g/ml). Results are from represen- 
tative experiments and were confirmed in two to three 
experimental sets each. 
Effect of Endothelioma Conditioned Medium on NOS 
Activity and Expression in HUVEC 
Since tEnd.1 NOS activity had features typical of an in- 
ducible form (Ca  2§  independence, inhibition by dexameth- 
asone and L-canavanine), we explored the possibility that en- 
dothelloma cells produce soluble factor(s) able to induce NOS 
synthesis in an autocrine way. HUVEC were incubated for 
24 h with medium previously incubated for 48 h with tend.1 
cells. At the end of incubation the HUVEC monolayer was 
washed, and NOS activity was measured in the lysate, pre- 
pared as previously described, in the presence of 2.5 #Ci (0.4 
#M) L-[3H]arginine. It is interesting to note that NOS ac- 
tivity increased 300-800-fold (n  --  3) and was found to be 
Ca  2+ independent; the substrate dependence of enzyme ac- 
tivity followed a typical Michaelis-Menten pattern (Fig.  7 
A).  Similar  results  were  obtained  with  the  conditioned 
medium from H.End.FB, HSV, and send.1 (data not shown). 
Conditioned medium from MAEC, N2A cells, mTa-infected 
N2A cells, and HUVEC transfected with K-ms, did not in- 
Figure  6.  Detection  of  eNOS 
and iNOS in HUVEC and tEnd.1 
cells. (.,4) immunoprecipitation of 
cell lysates (1.2 mg protein) from 
tEn&l cells,  HUVEC, and HUVEC 
stimulated  for  12  h  with  condi- 
tioned medium of tend.1 cells (CM- 
HUVEC)  with a mAb anti-human 
eNOS, followed by a Western blot 
analysis  using the same antibody. (B) 
Western blot analysis of whole cell 
lysate from tend.1 cells, HUVEC, 
and CM-HUVEC with a mAb anti- 
murine macrophage iNOS. We did 
not perform immunoprecipitation 
expetiments because this antibody 
did  not  work  in  such  technique 
using as positive control the routine 
J774 macrophage cell line. 
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Figure  7.  (.4) t-arginine dependence of NO synthase (NOS) from 
HUVEC after 24-h incubation  with 10 ml supernatant  of tEnd.1 (dose- 
dependence curve from an experiment representative  of three similar ex- 
periments performed  in duplicate).  (B) NOS activity  in HUVEC incubated 
for different  time  periods  with 10 ml supernatant  of  tEnd.1 (time-dependence 
curve from an experiment representative  of three similar  experiments  per- 
formed  in duplicate).  In both cases, supernatant  was DMEM supplemented 
with 10% FCS, that after 24-h incubation  with tEnd.1 was transferred 
in 100 mm--diameter  dishes containing  HUVEC at confluence.  At the 
end of the indicated  incubation  times, HUVEC were washed  three times 
with PBS and then checked  for NOS activity  as reported  in Materials  and 
Methods. Time dependence  was measured  by incubating  cell lysates  with 
0.4 #M L-[3H]arginine  alone, whereas in dose-dependence  experiments 
1-100 #M t-arginine was added. 
Table  2.  NOS Activity  in HUVEC Exposed to Diluted 
tend.1  Conditioned Medium 
Treatment  NOS  activity 
None 
Conditioned medium 
Conditioned medium (1:2) 
Conditioned medium (1:5) 
Conditioned medium (1:10) 
0.41  "I-_ 0.19 
34.1  +  3.4 
28.1  _+  2.3 
18.2  +  0.9 
2.1  _+  0.6 
HUVEC were incubated  with conditioned  medium of tend.1 cells sup- 
plemented  with 10% FCS differently  diluted  in DMEM containing  10% 
FCS. Measurement  of enzymatic  activity  was performed  as indicated  in 
Materials and Methods, in the presence of 2.5/~Ci (0.4/~M) t-[3H]ar  - 
ginine. NOS activity  is expressed  as pmol citruUine/min/mg  cell protein 
(mean _+ SEM of three experiments). 
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crease NOS activity in HUVEC (data not shown). The in- 
crease of NOS activity in HUVEC was already detectable 
after 3 h of incubation, and reached its maximum at 12-24  h 
(Fig. 7 B): in the presence of cycloheximide, NOS induction 
at 6 h was inhibited by 72  _  3% (n  --  3).  The effect was 
dose dependent and stimulation was maximal for nondiluted 
conditioned medium (Table 2). 
The stimulation of HUVEC for 12 h with conditioned 
medium from tEnd.1 cell increased the amount of NOS de- 
tected by an antibody recognizing human eNOS (Fig. 6 A). 
Cell lysate from HUVEC was immunoprecipitated with a 
mAb anti-human eNOS, followed by a Western blot anal- 
ysis using the same antibody. The treatment with conditioned 
medium from tEnd.1 cells for 12 h increased the amount of 
a 147-kD protein and caused the appearance of a 113-kD one, 
which is also present in tend.1 immunoprecipitate (Fig.  6 
A). On the other hand, the mAb anti-murine macrophage 
iNOS,  tested in Western blot performed on HUVEC cell 
lysate after stimulation with tEnd.1 conditioned medium, 
did not immunoreact with a  130-kD  protein  (Fig.  6 B). 
Moreover, conditioned medium-treated HUVEC did not ~- 
press mRNA for iNOS, even after preincubation with cyclo- 
heximide (data not shown). 
We performed a preliminary characterization  of the soluble 
factor, which we named NOS-activating factor (NAF), present 
in the tEnd.1 conditioned medium and responsible for NOS 
induction. As NAF was not extracted by organic solvents, 
we excluded that it was a lipid. It was resistant to treatment 
with DNase,  RNase, and dithiothreitol, but was sensitive 
to trypsin, chymotrypsin, and heating, thus supporting the 
hypothesis that it is a protein. Dialytic treatment of condi- 
tioned medium suggested a molecular weight higher than 
12,000.  NAF was retained by anion exchange chromatog- 
raphy and was eluted with NaC1 concentrations ranging from 
0.5 to 0.7 M. With affinity chromatography NAF did not 
bind to heparin or Con A at pH 7.4, suggesting the absence 
of net positive charges and glycosidic moieties containing man- 
nose (not shown). 
Inhibition  of Hemangioma  Growth  by the NOS 
Inhibitor L-Canavanine 
It was of interest to obtain preliminary indications as to 
whether production of NO has relevance in the tumorige- 
nicity of mTa endotheliomas. As recently described,  trans- 
plantation of H5V cells in syngeneic recipients causes subcu- 
taneous tumors which,  after a phase of growth, undergo 
rejection (18); a proportion of mice (70--90%)  experience  a 
second regrowth phase. We focused our attention on the effect 
of t-canavanine, the most potent in vitro inhibitor of en- 
dothelioma cell NOS activity, on tumor take, rejection, and 
regrowth, t-canavanine caused a significant reduction of tumor 
volumes throughout the period of first growth (Fig. 8). Pre- 
liminary histological analysis on hematoxylin-eosin-stained 
sections  revealed no substantial alteration in tumor texture 
and composition. Moreover,  only 1 of 8 canavanine-treated 
mice showed a regrowth, compared with 6 of 8 regrowths 
for control animals on day 60  (Fig.  9). []  control  []  L-canavanine 
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Figure 8.  Effect  of t-canavanine on H5V tumor growth. Mice (eight 
per group) were transplanted with 106 HSV cells s.c. on day 0, then 
treated with t-canavanine (30 mg/kg i.p.) or saline from day 0 to day 28. 
Tumor growth was estimated  by calipers at days reported  and tumor volume 
calculated as indicated in Materials and Methods. Owing to a spontaneous 
regression, after the second week the volume of tumors both in control 
and treated mice was too small to allow to check differences  between the 
two groups. Data are means _+ SEM. (*) p <0.05; (* *) p <0.01 (Stu- 
dent's t test). 
Discussion 
The middle T  oncogene of polyoma virus causes the de- 
velopment of endothelial tumors identified as hemangiomas 
in mice (16,  18). From these lesions endothelioma cell lines 
could be easily established from different organs. These cells 
express polyoma mTa, retain functional properties of normal 
endothelium, and cause hemangiomas in vivo when reinjected 
in mice (16, 19, 20). It is interesting to note that the in vivo 
vascular  lesions are formed by recruitment of host cells (18, 
20). Transformation  of endothelial cells by mouse polyoma 
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Figure  9.  Effect  of t-canavanine on H5V cells tumorigenicity. Mice 
treated as shown were checked for tumor appearance and growth three 
times a week. 
virus requires mTa alone: this protein both regulates and is 
a substrate for members of src tyrosine kinase family (30). 
Association of mTa with pp60  '-'~ results in the activation of 
the tyrosine kinase and  then association and phosphoryla- 
tion of a phosphatidylinositol 3-kinase (30). How these events 
lead to a mitogenic response is presently not well known. 
We  had  previously  used  mTa-transformed  mouse  en- 
dothelioma cells  as a good tool for analysis  of endothelial 
cell immunobiology: they responded to several cytokines by 
producing other cytokines, procoagulant activity, and platelet- 
activating factor (19). In the present work, we aimed to study 
whether mTa-transformed endothelial cells were able to pro- 
duce NO, and the mechanisms regulating NOS activity, in 
order to understand a possible involvement of NO in the en- 
dothelioma growth, especially as far as host cell recruitment 
is concerned. As a first screening, we measured NOS activity 
in the lysate of several types of endothelial  cells  (Table  1). 
A very high NOS activity was shared by endothelioma mouse 
cells from thymus (tEnd.I), skin (sEnd.I), and midgestation 
chimeric embryos (eEnd.1,  data not  shown),  as well as by 
rnTa-transformed endothelial cells from mouse heart (H.End.FB, 
H5V). On the other hand, nontransformed MAEC, HUVEC, 
and HUAEC exhibited a similar low activity. To establish 
the role of NO in endothdioma development and the pos- 
sible linkage of its production with mTa expression, we have 
chosen to study NO synthesis in tEnd.1. HUVEC were used 
as a normal, nontransformed control. Indeed, endothelial cells 
from mouse aorta exhibited the same pattern  of NO pro- 
duction  as human  endothelium  (Table 1),  but  were more 
difficult to be cultured at the amounts necessary to perform 
our experiments. 
tEnd.1 and HUVEC showed a striking difference in NO 
production, as measured by nitrite accumulation in the cul- 
ture medium and cell-associated [3H]citrulline synthesis. In 
aerobic biological systems, NO is oxidized to the more stable 
NO2-, which is easily detectable in the extracellular  medium 
by the Griess reagent (24). Nitrite accumulation in the medium 
was 10-fold higher in tEnd.1 than in HUVEC. In both call 
types it was arginine dependent and completely blocked by 
hemoglobin, a well known NO scavenger.  These data con- 
firmed that nitrite production was dependent on conversion 
of arginine into NO. At the contrary of nitrite assay (which 
requires at least 24 h of incubation to reach detectable amounts 
of substrate),  it is possible to measure short-term  (15 min) 
citruUine production in whole cells, by incubating them with 
[3H]arginine  and  detecting  the  amount  of cell-associated 
[3H]citrulline (14). Basal citrulline production was eightfold 
higher in tEnd.1 cells than in HUVEC. After ionomycin stim- 
ulation, citrulline synthesis increased in both cell types, but 
was still fivefold higher in endothelioma cells. Citrulline syn- 
thesis was again t-arginine  dependent,  and inhibited by 10 
mM [.-NMMA in the culture medium.  A further approach 
to citrulline detection is the colorimetric method by Boyde 
and Rahmatullah  (25), which recognizes the ureido group 
present in the molecule. By this less sensitive technique, after 
24 h  of incubation the citruUine accumulation was detect- 
able only in tEnd.1 medium but not in the HUVEC super- 
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t-arginine concentration. 
The radiometric method for citmlline detection is also useful 
to measure NOS activity in cell lysates (31). NOS kinetics 
in the two cell types differed significantly as far as maximal 
catalytic  activity was concerned:  Vmax was hundredsfold 
higher in tEnd.1 in comparison with HUVEC, suggesting 
the presence of a much higher amount of enzyme in mTa- 
transformed cells. On the other hand, Km was similar in both 
cases, providing evidence that the enzyme affinity for the sub- 
strate was the same. D-arginine was not transformed by the 
lysate in either cell type, and neither inhibited the enzyme 
activity, thus confirming the stereospecificity of NOS (8). 
The calcium dependence of NOS in HUVEC suggests that 
these cells contain the constitutive isoform of the enzyme. 
On the other hand, tend.1 NOS activity was not dependent 
on Ca  2  + in the reaction buffer, and was strongly inhibited 
by dexamethasone pretreatment (which did not affect enzyme 
activity in HUVEC). Such data provide evidence for an in- 
ducible form of NOS in tEnd.l, but the ability of ionomycin 
to enhance citruUine synthesis also in endothelioma cells sug- 
gests the existence of a Ca2+-dependent isoform too.  It is 
possible that in tEnd.1 the inducible and constitutive NOS 
isoforms  coexist,  as  observed  in  cytokine-stimulated  en- 
dothelium (24, 32). This hypothesis seems to be confirmed 
by the finding that, whereas HUVEC express only the tran- 
script for eNOS, in tend.1 mKNA for both isoforms is de- 
tectable. The iNOS transcript was measurable only after treat- 
ment with cycloheximide (an inhibitor of polypeptide chain 
elongation):  this result could be indicative of a rapid degra- 
dation of iNOS-mKNA, due to an elevated instability (33). 
This hypothesis is in agreement with kinetic results (high 
Vmax), that suggest an increased synthesis of catalytic units 
in tEnd.1. Interestingly enough, the higher synthesis of citrul- 
line by tEnd.t cells after ionomycin stimulus fits with the 
higher expression of cNOS-mRNA in these cells in compar- 
ison with HUVEC. 
NOS activity in the two cell types studied was different 
also in terms of sensitivity to several competitive inhibitors. 
HUVEC NOS was more sensitive  to t-NMMA and ~.-NAME, 
and highly resistant to t-canavanine inhibition.  On the con- 
trary, in tend.1 NOS activity was impaired by low concen- 
trations  of t-canavanine, whereas efficacy of t-NMMA was 
lower, and t-NAME was virtually uneffective. A different 
sensitivity of the inducible and constitutive isoforms of NOS 
to inhibitors has been already described (24, 34), and t-cana- 
vanine has been indicated as a more selective inhibitor of the 
macrophage inducible form of NOS (15). 
Our results show that mTa-transformed  endothelioma cells 
possess an elevated NOS activity, which is probably due to 
induction of a de novo synthesis of enzyme molecules. As 
ras-transformed HUVEC did not exhibit NOS hyperactivity, 
such a feature is not a simple consequence of cell transforma- 
tion, but requires expression of raTa. On the other hand, ex- 
pression of raTa in nonendothelial  cell lines was not accom- 
panied  by  an  increase of NOS  activity,  suggesting  that 
mTa-elicited NOS overexpression is tissue specific. 
It is difficult to define the possible role of NO in the trans- 
formation of murine endothelial cells. NO has been demon- 
strated to inhibit cell proliferation, probably owing to inhi- 
bition of GAPDH, ribonudeotide reductase,  and mitochondrial 
respiration (35). For this reason, it would be hard to suppose 
the involvement of NO in the mTa-evoked  mitogenic stimulus. 
On the other hand, the cytotoxic activity of NO could im- 
pair the functions of the immune system cells, thus favoring 
the tumor progression: it has been observed that NO produc- 
tion can account for immunosuppression  induced by colon 
adenocarcinoma cells in rat monocytes (36). Our in vivo ex- 
periments led us to hypothesize a role for NO in the genesis 
of hemangiomas:  administration  of t-canavanine  to endo- 
thelioma-bearing mice significantly reduced both the volume 
of subcutaneous angiomas, and (after a transient phase of com- 
plete remission) their regrowth, thus suggesting that NO 
is necessary to the tumor development. An interesting fea- 
ture of the in vivo vascular  lesions is that >95% of endothelial 
cells from hemangiomas are host derived (20). The continuous 
presence of endothelioma cells is necessary to maintain the 
tumor, supporting the hypothesis that endothelioma cells pro- 
duce an hemangioma-inducing activity. The recruitment of 
host cells does not depend on the release of mitogenic or an- 
giogenic soluble factors, but requires a tight cell-to-cell con- 
tact, since  the putative signal is only active over a short dis- 
tance. Such features could be applied to NO, a free radical 
that, having a 3-5 s half-life, cannot diffuse beyond the space 
corresponding to a single cell diameter (34). Thus it can be 
hypothesized that NO released  from endothelioma cells favors 
the recruitment of normal endothelial cells in the vascular 
lesions: this suggestion is confirmed by recent data demon- 
strating that the synthesis of NO is necessary for production 
of angiogenic activity by LPS-stimulated human monocytes 
(37). During hemangioma development,  the endothelioma 
cells may first integrate  into blood vessels, leading to their 
rupture: NO could also participate  to this process, owing 
to its characteristics of vasodilator and cytotoxic agent. The 
effect of t-canavanine on tumor growth in mice is in agree- 
ment with this hypothesis. 
Finally, our preliminary results with conditioned medium 
from tend.1 support the idea that endothelioma cells release 
a soluble factor (NAF) able to induce eNOS activity both 
in endothelioma cells and in normal endothelial cells. An eNOS 
with a molecular  mass of 147 kD was present  in resting 
HUVEC: after treatment with tend.1 conditioned medium, 
the amount of this protein increased consistently, coupled 
with the appearance of a 113-kD protein. A similar doublet 
is present in tend.1 (Fig. 6 A) and in COS-7 cells transfected 
with eNOS eDNA (38). mRNA for iNOS and iNOS protein 
are not expressed in HUVEC after stimulation with tEnd.1 
conditioned medium. So far, the high NOS activity present 
in NAF-stimulated HUVEC is attributable to the induction 
of an enzyme detected by an anti-eNOS mAb (Fig. 6 A). 
On the other hand, the in vitro Ca  2  + independence of the 
enzyme and its inducibility by a soluble factor are not criteria 
sufficient (39) to classify NAF-induced NOS in HUVEC as 
an iNOS. Indeed, the Ca  2+/calmodulin-dependent  NOS in 
17  Ghigo et al. human hepatocyte possesses a 80% homology with macro- 
phage iNOS (40), and the cytokine-induced NOS activity 
in rabbit chondrocytes is Ca  2+  dependent  (41). 
Our preliminary experiments provide evidence that NAF 
is a thermolabile,  anionic protein with a size >12 kD. The 
release of a NOS-inducing activity has already been reported 
in different cells: culture medium from rat colon carcinoma 
cells induces NOS activity in splenic macrophages (36), cul- 
ture supernatant from activated macrophages evokes NO syn- 
thesis in the murine adenocarcinoma cell line EMT-6 (42), 
transferable products from Kupffer cells elicit conversion of 
t-arginine  to NO in hepatocytes (43),  and P1HTR. tumor 
cells stimulate murine macrophages to produce NO (44). Till 
now, no evidence has been provided about the feature of the 
soluble factor(s) involved. 
Our results suggest the following hypotheses, raTa trans- 
formation evokes the synthesis of soluble factor(s) which may 
be responsible for the high NOS activity in tEnd.l,  that is 
mainly present as the inducible form. It is conceivable that, 
when few endothelioma cells settle in a vascular district, they 
recruit the first host cells via NO synthesis. NO could also 
impair  the  host  immune  response  against  the  developing 
tumor. After few hours, endothelial normal cells are converted 
by an endothelioma-derived soluble factor into potent NO 
producers,  that cooperate with endothelioma cells in recruiting 
new host cells. This "cascade" model can account for the need 
of very low amounts of tumoral cells to evoke the onset of 
the vascular lesions. 
In our laboratory we are currently  trying to purify the 
soluble factor(s) responsible for NOS-inducing activity and 
present in mTa-endothelioma conditioned medium. It is pos- 
sible that NAF is related to (or can be identified with) the 
40-kD  cytokine, derived from mTa-transformed  cells,  that 
evokes migration of vascular endothelial cells (18). The char- 
acterization of this molecule(s) could provide new informa- 
tion about the genesis and maintenance of vascular tumors, 
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